Kennedy Lawrence T. Jr's Form 4 filing
Biodesix Inc (BDSX) · filed Jan 5, 2023
- Accession no.
- 0001140361-23-000723
- Filed
- Jan 5, 2023
- Trade date
- Nov 21, 2022
- Filing delay
- 45 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $12.5M. It was filed 45 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kennedy Lawrence T. JrCIK 0001830773 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2022 | Common Stock | PPurchaseAcquired | +8,260,869 | $1.15 | +$9,499,999.35 | 9,148,889 | Indirect | |
| Nov 21, 2022 | Common Stock | PPurchaseAcquired | +2,608,696 | $1.15 | +$3,000,000.4 | 4,355,914 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney